Balaxi Pharmaceuticals consolidated net profit rises 65.13% in the December 2023 quarter
Sales decline 29.79% to Rs 60.79 crore
Net profit of Balaxi Pharmaceuticals rose 65.13% to Rs 13.59 crore in the quarter ended December 2023 as against Rs 8.23 crore during the previous quarter ended December 2022. Sales declined 29.79% to Rs 60.79 crore in the quarter ended December 2023 as against Rs 86.58 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales60.7986.58 -30 OPM %22.4717.67 -PBDT13.1110.71 22 PBT12.6310.53 20 NP13.598.23 65Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 09 2024 | 4:17 PM IST